Tetragon Partners GP Ltd Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001515070

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedTechnology TiltHigh Turnover how tags are computed

Q4 2024 · 24 positions · Total reported value $292.97M · Top-10 concentration 85.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.5% · 4 new · 5 cut · 6 exited

Active Share (vs S&P 500): 99.7% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +7.8% · vs SPY +5.7% · Prev Value $613.69M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.0% · vs SPY +2.8% · Latest Value $730.98M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, Tetragon Partners GP Ltd disclosed 24 equity positions with a combined reported value of $292.97M. The filing implies a focused portfolio: its ten largest positions account for 85.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Technology Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were PATH ($88.33M), KGEI ($37.62M), AUTL ($19.39M). By sector, the heaviest allocations are Technology 38.4%, Health Care 18.7%. Versus the prior quarter, allocation shifted toward Energy (+5.2pp), Technology (+2.3pp) and away from Consumer Discretionary (-1.5pp), Health Care (-2.1pp).

Versus the prior quarter, Tetragon Partners GP Ltd opened 4 new positions, trimmed 5 and fully exited 6, a turnover rate of 37.5% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q4 2024 were CLDX ($4.85M), BBAI ($4.00M), AXSM ($3.49M).

Of the 6 positions fully exited versus the prior quarter, the largest were BALY ($4.80M), NEWS ($754.25K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • CLDX CELLDEX THERAPEUTICS INC NEW · $4.85M
  • BBAI BIGBEAR AI HLDGS INC · $4.00M
  • AXSM AXSOME THERAPEUTICS INC. · $3.49M
  • KROS KEROS THERAPEUTICS INC · $1.63M
  • BVN COMPANIA DE MINAS BUENAVENTU · $426.24K

Fully Exited (vs previous quarter)

  • BALY BALLYS CORPORATION · prev qtr: $4.80M
  • NEWS NOBLE CORP PLC · prev qtr: $754.25K

Insider Transactions (Form 4)

Latest Tetragon Partners GP Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Tetragon Partners GP Ltd files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 36 positions worth $613.69M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 36 positions · $613.69M reported value (Q2 2026)
  • Top 10 holdings = 76.6% of reported value
  • Largest position: PATH (UIPATH INC CL A) at 54.8%
  • Average position size: $17.05M

Sector Tilt

  • Information Technology 60.8%
  • Health Care 30.2%
  • Energy 5.5%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 16 added, 7 reduced, 4 exited
  • 7 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 38.4%
Health Care 18.7%
Energy 12.8%
Materials 5.1%
Other 9.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 6.95M $88.33M 30.15%
30.15%
Hold
2 7.07M $37.62M 12.84%
12.84%
Hold
3 8.25M $19.39M 6.62%
6.62%
Add
4 20.00M $19.38M 6.61%
6.61%
Add
5 2.20M $18.59M 6.34%
6.34%
Hold
6 600.00K $15.56M 5.31%
5.31%
Add
7 19.14M $14.18M 4.84%
4.84%
Add
8 15.50M $14.10M 4.81%
4.81%
Reduce
9 1.00M $12.90M 4.40%
4.40%
Hold
10 200.00K $11.07M 3.78%
3.78%
Reduce
11 6.00M $7.29M 2.49%
2.49%
Hold
12 1.40M $7.18M 2.45%
2.45%
Add
13 90.33K $7.10M 2.42%
2.42%
Reduce
14 192.00K $4.85M 1.66%
1.66%
New
15 900.00K $4.00M 1.37%
1.37%
New
16 902.50K $3.56M 1.22%
1.22%
Add
17 41.25K $3.49M 1.19%
1.19%
New
18 103.00K $1.63M 0.56%
0.56%
New
19 10.00K $1.54M 0.53%
0.53%
Hold
20 58.00K $469.94K 0.16%
0.16%
Reduce
21 37.00K $426.24K 0.14%
0.14%
New
22 6.37K $258.10K 0.09%
0.09%
Reduce
23 301.80K $33.53K 0.01%
0.01%
Hold
24 18.90K $121 0.00%
0.00%
Hold

FAQ

What did Tetragon Partners GP Ltd buy in 2024-Q4?

In its 2024-Q4 13F filing, Tetragon Partners GP Ltd reported 24 equity positions worth $292.97M in aggregate; its largest disclosed positions were PATH ($88.33M), KGEI ($37.62M), AUTL ($19.39M).

How large is Tetragon Partners GP Ltd's portfolio?

Tetragon Partners GP Ltd reported $292.97M of long equity holdings across 24 positions as of 2024-Q4. Top-10 holdings account for 85.7% of reported value.

What is Tetragon Partners GP Ltd's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tetragon-partners-gp/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →